AAPG Stock Analysis: Buy, Sell, or Hold?
AAPG - Ascentage Pharma Group International American Depository Shares
$16.46
0.36 (2.24%)
▲
5d:
-6.56%
30d:
-13.23%
90d:
-3.8%
WAIT
LOW Confidence
Analysis Updated: Sep 14, 2026 12:00 AM ET
Earnings: Aug 19, 2026
0d
Get Alerted When AAPG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AAPG shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AAPG shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: AAPG is currently trading at $16.46, which is considered oversold relative to its 30-day fair value range of $16.67 to $18.50.
Technical Outlook: Technically, AAPG is in a downtrend. The price is currently testing key support at $16.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $47.12 (+192.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AAPG is in a downtrend. The price is currently testing key support at $16.03. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $47.12 (+192.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$16.67 -
$18.50
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 192.7% below Wall St target ($47.12)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$16.67 -
$18.50
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$16.03
Resistance Level
$17.78
Current Trend
Downtrend
Technical data as of
Sep 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.53
Wall Street Target
$47.13
(+192.7%)
Revenue Growth (YoY)
29.3%
Profit Margin
-228.5%
Share & Embed Analysis
Last updated: September 14, 2026 1:16 PM ET
Data refreshes hourly during market hours. Next update: 2:16 PM
Data refreshes hourly during market hours. Next update: 2:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AAPG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$27 | 48 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 49 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 48 HOLD |
|
LRMR
Larimar Therapeutics Inc |
STRONG BUY
11 analysts |
$14 | 65 BUY |
